Allergen-specific immunotherapy and risk of autoimmune disease
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Allergen-specific immunotherapy and risk of autoimmune disease. / Linneberg, Allan; Madsen, Flemming; Skaaby, Tea.
I: Current Opinion in Allergy and Clinical Immunology, Bind 12, Nr. 6, 2012, s. 635-9.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Allergen-specific immunotherapy and risk of autoimmune disease
AU - Linneberg, Allan
AU - Madsen, Flemming
AU - Skaaby, Tea
PY - 2012
Y1 - 2012
N2 - After 100 years of experience with allergen-specific immunotherapy (SIT), an issue that is still unresolved is whether SIT can act as a trigger of, or as a risk factor for, autoimmune disease. We searched the literature for evidence on this topic.
AB - After 100 years of experience with allergen-specific immunotherapy (SIT), an issue that is still unresolved is whether SIT can act as a trigger of, or as a risk factor for, autoimmune disease. We searched the literature for evidence on this topic.
U2 - http://dx.doi.org/10.1097/ACI.0b013e3283588c8d
DO - http://dx.doi.org/10.1097/ACI.0b013e3283588c8d
M3 - Journal article
VL - 12
SP - 635
EP - 639
JO - Current Opinion in Allergy and Clinical Immunology
JF - Current Opinion in Allergy and Clinical Immunology
SN - 1528-4050
IS - 6
ER -
ID: 48513171